DISBROW JARRETT (Chief Operating Officer) purchased 130.2% of their position (16.67K shares) of AYTU BIOPHARMA, INC on the open market
Open‑market purchase worth $25.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/10/2025ACC: 0001437749-25-019958
Officer· Chief Operating Officer
Since Oct 2018
+16.67K
Net shares
Net buyer
$25.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
16.67K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+16.67K
Price / share
$1.50
Trade value
$25K
% of position
130.2%
6/9/2025
12.80K→29.46K
Total
Net shares
+16.67K
Net value
$25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/9/2025 | P · Purchase | +16.67K | $1.50 | $25K | 130.2% | 12.80K | 29.46K |
| Total | +16.67K | $25K | ||||||
Derivative Transactions0
No derivative transactions reported